6336 related articles for article (PubMed ID: 2921610)
1. Effects of coumarin (1,2-benzopyrone) and cimetidine on peripheral blood lymphocytes, natural killer cells, and monocytes in patients with advanced malignancies.
Marshall ME; Riley LK; Rhoades J; Eichhorn T; Jennings CD; Cibull M; Thompson J
J Biol Response Mod; 1989 Feb; 8(1):62-9. PubMed ID: 2921610
[TBL] [Abstract][Full Text] [Related]
2. Effects of coumarin (1,2-benzopyrone) on lymphocyte, natural killer cell, and monocyte functions in vitro.
Marshall ME; Conley D; Hollingsworth P; Brown S; Thompson JS
J Biol Response Mod; 1989 Feb; 8(1):70-85. PubMed ID: 2921611
[TBL] [Abstract][Full Text] [Related]
3. Effects of perioperative cimetidine administration on peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: results of a randomized controlled clinical trial.
Li Y; Yang GL; Yuan HY; Bai DJ; Wang K; Lin CR; Hu MB; Feng MH
Hepatogastroenterology; 2005; 52(62):504-8. PubMed ID: 15816467
[TBL] [Abstract][Full Text] [Related]
4. Coumarin (1,2-benzopyrone) enhances DR and DQ antigen expressions by peripheral blood mononuclear cells in vitro.
Marshall ME; Rhoades JL; Mattingly C; Jennings CD
Mol Biother; 1991 Dec; 3(4):204-6. PubMed ID: 1768372
[TBL] [Abstract][Full Text] [Related]
5. Phase I evaluation of coumarin (1,2-benzopyrone) and cimetidine in patients with advanced malignancies.
Marshall ME; Butler K; Fried A
Mol Biother; 1991 Sep; 3(3):170-8. PubMed ID: 1768368
[TBL] [Abstract][Full Text] [Related]
6. Combined treatment of advanced malignant melanoma with coumarin and cimetidine.
Nolte H; Pedersen L; Mouridsen HT
Anticancer Res; 1987; 7(3 Pt B):449-50. PubMed ID: 3631904
[TBL] [Abstract][Full Text] [Related]
7. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
9. Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.
Allen JI; Perri RT; McClain CJ; Kay NE
J Lab Clin Med; 1983 Oct; 102(4):577-89. PubMed ID: 6604771
[TBL] [Abstract][Full Text] [Related]
10. Decrease in helper (T4+) lymphocytes following cimetidine treatment for duodenal ulcer.
Hast R; Bernell P; Befrits R; Dowding C; Sjögren AM
Clin Exp Immunol; 1986 Apr; 64(1):114-8. PubMed ID: 2942318
[TBL] [Abstract][Full Text] [Related]
11. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
Atzpodien J; Gulati SC
Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study.
Marshall ME; Butler K; Hermansen D
Prostate; 1990; 17(2):95-9. PubMed ID: 2399194
[TBL] [Abstract][Full Text] [Related]
13. The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma.
Kikuchi Y; Oomori K; Kizawa I; Kato K
Jpn J Clin Oncol; 1985 Jun; 15(2):377-83. PubMed ID: 3839542
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive activity of L-leucyl-L-leucine methyl ester: selective ablation of cytotoxic lymphocytes and monocytes.
Thiele DL; Lipsky PE
J Immunol; 1986 Feb; 136(3):1038-48. PubMed ID: 2934477
[TBL] [Abstract][Full Text] [Related]
16. Immunological effects of recombinant interferon-alpha 2 in cancer patients.
Hengst JC; Kempf RA; Kan-Mitchell J; Pham AT; Grunberg SM; Kortes VL; Mitchell MS
J Biol Response Mod; 1983; 2(6):516-27. PubMed ID: 6663321
[TBL] [Abstract][Full Text] [Related]
17. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.
Donskov F; Bennedsgaard KM; Hokland M; Marcussen N; Fisker R; Madsen HH; Fode K; von der Maase H
Cancer Immunol Immunother; 2004 Aug; 53(8):729-39. PubMed ID: 15088127
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
20. [Immunological study of the postoperative adjuvant treatment with interferon gamma in patients with renal cell cancer--measurement of peripheral blood lymphocyte subsets with three color flow cytometry].
Yasunaga Y; Nishimura K; Miura H; Takatera H; Kuroda H; Kishimoto T; Fujioka H
Hinyokika Kiyo; 1995 Feb; 41(2):85-92. PubMed ID: 7702012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
